The weekly litigation news digest is live. Subscribe now

IP Verse

Ribociclib Tablet - EP3283058

The patent EP3283058 was granted to Novartis on Nov 16, 2022. The application was filed on Apr 14, 2016 under application number EP16718020A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3283058

NOVARTIS
Application Number
EP16718020A
Filing Date
Apr 14, 2016
Status
Granted And Under Opposition
Oct 14, 2022
Publication Date
Nov 16, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
STADA ARZNEIMITTELAug 16, 2023HAMM & WITTKOPPADMISSIBLE
ADALVOAug 15, 2023SLAVIKADMISSIBLE
GENERICS UKAug 15, 2023ELKINGTON AND FIFEADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2010020675
DESCRIPTIONWO2012064805
INTERNATIONAL-SEARCH-REPORTEP2742940
INTERNATIONAL-SEARCH-REPORTWO2012064805
INTERNATIONAL-SEARCH-REPORTWO2014097125
OPPOSITIONEP2742940
OPPOSITIONUS5885617
OPPOSITIONWO2012064805
OPPOSITIONWO2014097125
OPPOSITIONWO2016166703
OPPOSITIONWO2022064805

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents